Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.
BCI® Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other ...
Medical Device Network on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
New research suggests pain is not a simple signal of injury but a process that unfolds across nerves, spinal cord, and brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results